Breast, Colorectal Cancer Screening Higher Than Lung Cancer Screening

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 15, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, April 15, 2025 -- Among individuals eligible for lung cancer screening (LCS), use of breast cancer screening (BCS) and colorectal cancer screening (CCS) is much higher than use of LCS, according to a research letter published online April 2 in the Journal of the American Medical Association.

Alexandra L. Potter, from Massachusetts General Hospital in Boston, and colleagues examined use of other cancer screening tests among U.S. adults eligible for LCS and those ineligible for LCS. Participants aged 50 to 79 years in the 2022 U.S. Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System (BRFSS) dataset were classified according to whether they met the U.S. Preventive Services Task Force criteria for LCS. LCS-eligible participants were further classified according to whether they were eligible for BCS and CCS.

Of the 212,393 BRFSS participants who met the study inclusion criteria, 28,483 were eligible for LCS. Overall, 11,147 and 24,172 BRFSS participants were included in the LCS/BCS and the LCS/CCS dual-eligibility cohorts, respectively. The researchers found that in the LCS/BCS dual-eligibility cohort, 65.0 percent underwent BCS and 17.0 percent underwent LCS. In the LCS/CCS dual-eligibility cohort, 64.7 percent underwent CCS and 17.5 percent underwent LCS. Among LCS-eligible participants who had never undergone LCS, 60.2 and 58.7 percent underwent BCS and CCS, respectively. In nearly all subgroups, receipt of CCS and BCS was at least three times higher than LCS.

"The results highlight the need for interventions to increase awareness about LCS and to reduce barriers," the authors write.

One author disclosed ties to the pharmaceutical and biotechnology industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-16 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords